A randomized Phase III trial of thoracoscopic versus open esophagectomy for thoracic esophageal cancer: Japan Clinical Oncology Group Study JCOG1409

Japanese Journal of Clinical Oncology

Volumn 46, Issue 2, 2016, Pages 174-177

  Kataoka, Kozo ^a   Takeuchi, Hiroya ^b   Mizusawa, Junki ^a   Ando, Masahiko ^c   Tsubosa, Yasuhiro ^d   Koyanagi, Kazuo ^e   Daiko, Hiroyuki ^f   Matsuda, Satoru ^b   Nakamura, Kenichi ^a   Kato, Ken ^e   Kitagawa, Yuko ^b  

^a NATIONAL CANCER CENTER   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NAGOYA UNIVERSITY HOSPITAL   (Japan)

^d SHIZUOKA CANCER CENTER   (Japan)

^e NATIONAL CANCER CENTER HOSPITAL   (Japan)

^f NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Open esophagectomy; Phase III; Thoracoscopic esophagectomy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CONVERSION TO OPEN SURGERY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; INTERMETHOD COMPARISON; JAPAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE PERIOD; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECURRENCE FREE SURVIVAL; REOPERATION; RESPIRATORY FAILURE; SURGICAL APPROACH; THORACIC ESOPHAGEAL CANCER; VERY ELDERLY; VIDEO ASSISTED THORACOSCOPIC SURGERY; VIDEORECORDING; ADVERSE EFFECTS; BREATHING; CLINICAL TRIAL; DISEASE FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PATIENT SELECTION; PROCEDURES; THORACOSCOPY; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PATIENT SELECTION; POSTOPERATIVE PERIOD; QUALITY OF LIFE; RESPIRATION; THORACOSCOPY; TREATMENT OUTCOME;

EID: 84961612875     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyv178     Document Type: Article

References (20)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Herskovic A, Martz K, al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593-8.
3. Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999;281:1623-7.
4. Shitara K, Muro K. Chemoradiotherapy for treatment of esophageal cancer in Japan: current status and perspectives. Gastrointest Cancer Res 2009;3:66-72.
5. Fujita H, Kakegawa T, Yamana H, et al. Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy. Ann Surg 1995; 222:654-62.
6. Kinugasa S, Tachibana M, Yoshimura H, et al. Postoperative pulmonary complications are associated with worse short- and long-term outcomes after extended esophagectomy. J Surg Oncol 2004;88:71-7.
7. Fang WT, Chen WH, Chen Y, Jiang Y. Selective three-field lymphadenectomy for thoracic esophageal squamous carcinoma. Dis Esophagus 2007;20:206-11.
8. Grogan EL, Jones DR. VATS lobectomy is better than open thoracotomy:what is the evidence for short-term outcomes? Thorac Surg Clin 2008; 18:249-58.
9. Cuschieri A, Shimi S, Banting S. Endoscopic oesophagectomy through a right thoracoscopic approach. J R Coll Surg Edinb 1992;37:7-11.
10. DantocMM, Cox MR, Eslick GD. Does minimally invasive esophagectomy (MIE) provide for comparable oncologic outcomes to open techniques? A systematic review. J Gastrointest Surg 2012;16:486-94.
11. Nagpal K, Ahmed K, Vats A, et al. Is minimally invasive surgery beneficial in the management of esophageal cancer? A meta-analysis. Surg Endosc 2010;24:1621-9.
12. Luketich JD, Pennathur A, Awais O, et al. Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg 2012;256:95-103.
13. Biere SS, van Berge Henegouwen MI, Maas KW, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet 2012;379:1887-92.
14. Luketich J, Pennathur A, Catalano P, et al. Results of a phase II multicenter study of minimally invasive esophagectomy (Eastern Cooperative Oncology Group Study E2202). J Clin Oncol 2009; 27:4516.
15. Nozaki I, Kato K, Igaki H, et al. Evaluation of safety profile of thoracoscopic esophagectomy for T1bN0M0 cancer using data from JCOG0502:a prospective multicenter study. Surg Endosc 2015; [Epub ahead of print].
16. Takeuchi H, Miyata H, Gotoh M, et al. A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database. Ann Surg 2014;260:259-66.
17. Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. Chichester, UK: John Wiley & Sons 2011.
18. Japan esophageal Society. Japanese classification of esophageal cancer, 11th edn. Tokyo: Kanehara & Co 2015.
19. Schoenfeld DA, Richter JR. Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint. Biometrics 1982;38:163-70.
20. Lan KG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983;70:659-63.